Tag:
CureDM
Latest Headlines
Latest Headlines
Sanofi inks $335M diabetes deal with CureDM
Sanofi-Aventis ( NYSE: SNY ) has signed a $335 million deal for the exclusive worldwide license of CureDm's Pancreate, a treatment for Type 1 and Type 2 diabetes. Phase I trials of the drug are
